{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:04:12Z","timestamp":1793289852320,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ahj.2014.12.009","type":"journal-article","created":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T12:19:27Z","timestamp":1420546767000},"page":"323-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["A reappraisal of loop diuretic choice in heart failure patients"],"prefix":"10.1016","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5605-8146","authenticated-orcid":false,"given":"Jonathan","family":"Buggey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Mentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5880-275X","authenticated-orcid":false,"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Eisenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Anstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2014.12.009_bb0005","first-page":"e28","article-title":"Heart Disease and Stroke Statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.12.009_bb0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jacc.2008.03.061","article-title":"Heart failure-related hospitalization in the U.S., 1979 to 2004","volume":"52","author":"Fang","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.2012.216476","article-title":"Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia","volume":"309","author":"Dharmarajan","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2014.12.009_bb0020","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2014.12.009_bb0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ejhf.74","article-title":"Decongestion in acute heart failure","volume":"16","author":"Mentz","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2014.12.009_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2014.12.009_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000164149","article-title":"Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry","volume":"113","author":"Peacock","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.ahj.2014.12.009_bb0040","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.jacc.2011.10.910","article-title":"Diuretics and ultrafiltration in acute decompensated heart failure","volume":"59","author":"Felker","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0045","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.cardfail.2013.06.132","article-title":"A two-symptom congestion score in relation to outcomes after discharge with acute decompensated heart failure","volume":"19","author":"Lala","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2014.12.009_bb0050","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2014.12.009_bb0055","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/j.1552-4604.1998.tb04810.x","article-title":"Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure","volume":"38","author":"Bleske","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/clpt.1994.98","article-title":"The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency","volume":"56","author":"Gehr","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2014.12.009_bb0065","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0002-9343(98)00111-9","article-title":"The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure","volume":"104","author":"Gottlieb","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2014.12.009_bb0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/clpt.1993.116","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis","volume":"54","author":"Schwartz","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2014.12.009_bb0075","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0009-9236(95)90222-8","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure","volume":"57","author":"Vargo","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2014.12.009_bb0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00045391-199506000-00010","article-title":"Effect of food on the pharmacokinetics and pharmacodynamics of torsemide","volume":"2","author":"Kramer","year":"1995","journal-title":"Am J Ther"},{"key":"10.1016\/j.ahj.2014.12.009_bb0085","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1365-2125.1996.00494.x","article-title":"Effect of food on the absorption of frusemide and bumetanide in man","volume":"42","author":"McCrindle","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ki.1984.153","article-title":"Bumetanide and furosemide in heart failure","volume":"26","author":"Brater","year":"1984","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2014.12.009_bb0095","first-page":"473","article-title":"A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states","volume":"22","author":"Sagar","year":"1984","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0100","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1185\/03007998809111119","article-title":"An open comparative study of two diuretic combinations, frusemide\/amiloride (\u2018Frumil\u2019) and bumetanide\/potassium chloride (\u2018Burinex\u2019 K), in the treatment of congestive cardiac failure in hospital out-patients","volume":"10","author":"Ramsay","year":"1988","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ahj.2014.12.009_bb0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7326\/0003-4819-102-3-314","article-title":"Furosemide absorption altered in decompensated congestive heart failure","volume":"102","author":"Vasko","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2014.12.009_bb0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1527-5299.2003.02399.x","article-title":"Pharmacotherapy in congestive heart failure: drug absorption in the management of congestive heart failure: loop diuretics","volume":"9","author":"Sica","year":"2003","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.ahj.2014.12.009_bb0115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/j.1875-9114.1997.tb03681.x","article-title":"Variable furosemide absorption and poor predictability of response in elderly patients","volume":"17","author":"Murray","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ahj.2014.12.009_bb0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/clpt.1994.100","article-title":"The pharmacodynamics of torsemide in patients with congestive heart failure","volume":"56","author":"Vargo","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2014.12.009_bb0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/tpj.2010.68","article-title":"The genetics of loop diuretic effects","volume":"12","author":"Vormfelde","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.ahj.2014.12.009_bb0130","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ijcard.2012.10.007","article-title":"The past, present and future of renin-angiotensin aldosterone system inhibition","volume":"167","author":"Mentz","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0135","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCRESAHA.110.238550","article-title":"Translational success stories: angiotensin receptor 1 antagonists in heart failure","volume":"109","author":"Dell'Italia","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2014.12.009_bb0140","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/01.HYP.30.2.222","article-title":"Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways","volume":"30","author":"Touyz","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2014.12.009_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tem.2012.09.004","article-title":"Aldosterone and cardiovascular disease: the heart of the matter","volume":"24","author":"He","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ahj.2014.12.009_bb0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","article-title":"Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure","volume":"93","author":"Qin","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2014.12.009_bb0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1291\/hypres.31.363","article-title":"Aldosterone nongenomically produces NADPH oxidase-dependent reactive oxygen species and induces myocyte apoptosis","volume":"31","author":"Hayashi","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ahj.2014.12.009_bb0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.HYP.26.1.137","article-title":"Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated renin secretion","volume":"26","author":"He","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2014.12.009_bb0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/hrt.57.1.17","article-title":"Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics","volume":"57","author":"Bayliss","year":"1987","journal-title":"Br Heart J"},{"key":"10.1016\/j.ahj.2014.12.009_bb0170","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","article-title":"Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial","volume":"9","author":"Hasselblad","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2014.12.009_bb0175","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.12.009_bb0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.12.009_bb0185","first-page":"1520","article-title":"Pharmacological properties of the new potent diuretic torasemide in rats and dogs","volume":"35","author":"Ghys","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ahj.2014.12.009_bb0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(91)90812-5","article-title":"Anti-aldosteronergic effect of torasemide","volume":"205","author":"Uchida","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0195","doi-asserted-by":"crossref","first-page":"PL45","DOI":"10.1016\/S0024-3205(98)00265-3","article-title":"Torsemide inhibits aldosterone secretion in vitro","volume":"63","author":"Goodfriend","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.ahj.2014.12.009_bb0200","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1253\/circj.67.384","article-title":"Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure","volume":"67","author":"Yamato","year":"2003","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2014.12.009_bb0205","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9149(99)80353-1","article-title":"Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease","volume":"76","author":"Barr","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0210","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.jacc.2004.09.009","article-title":"Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure","volume":"44","author":"Tsutamoto","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2014.12.009_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0073737","article-title":"The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes","volume":"8","author":"Gravez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2014.12.009_bb0220","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jacc.2004.04.059","article-title":"Furosemide and the progression of left ventricular dysfunction in experimental heart failure","volume":"44","author":"McCurley","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0225","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(01)01116-0","article-title":"Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure","volume":"37","author":"Tsutamoto","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0230","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0735-1097(00)00796-8","article-title":"Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure","volume":"36","author":"Tsutamoto","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0235","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0735-1097(01)01539-X","article-title":"Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction","volume":"38","author":"Hayashi","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. 1","key":"10.1016\/j.ahj.2014.12.009_bb0240","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ndt\/16.suppl_1.14","article-title":"Effects of loop diuretics on angiotensin II\u2013stimulated vascular smooth muscle cell growth","volume":"16","author":"Muniz","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ahj.2014.12.009_bb0245","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.12.009_bb0250","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.12.009_bb0255","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/CIRCULATIONAHA.109.912774","article-title":"Circulating biomarkers of collagen metabolism in cardiac diseases","volume":"121","author":"Lopez","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.12.009_bb0260","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/01.CIR.101.14.1729","article-title":"Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease","volume":"101","author":"Querejeta","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.12.009_bb0265","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.CIR.0000140973.60992.9A","article-title":"Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis","volume":"110","author":"Querejeta","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.12.009_bb0270","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure","volume":"43","author":"Lopez","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0275","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2007.04.080","article-title":"Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure","volume":"50","author":"Lopez","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0280","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.clinthera.2011.08.006","article-title":"Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study","volume":"33","author":"Group TI","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.ahj.2014.12.009_bb0285","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bcp.2007.09.026","article-title":"Comparative effects of torasemide and furosemide in rats with heart failure","volume":"75","author":"Veeraveedu","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"31 Suppl.","key":"10.1016\/j.ahj.2014.12.009_bb0290","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00541464","article-title":"Torasemide, a new potent diuretic. Double-blind comparison with furosemide","author":"Broekhuysen","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl.","key":"10.1016\/j.ahj.2014.12.009_bb0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00541465","article-title":"Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study","volume":"31","author":"Scheen","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0300","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1388-9842(03)00150-8","article-title":"Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV\u2014efficacy and quality of life","volume":"5","author":"M\u00fcller","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2014.12.009_bb0305","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9343(01)00903-2","article-title":"Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure","volume":"111","author":"Murray","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2014.12.009_bb0310","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/hrt.2005.079764","article-title":"Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure","volume":"92","author":"Kasama","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2014.12.009_bb0315","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","article-title":"Torasemide in chronic heart failure: results of the TORIC study","volume":"4","author":"Cosin","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2014.12.009_bb0320","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2217\/fca.12.54","article-title":"Should torsemide be the loop diuretic of choice in systolic heart failure?","volume":"8","author":"DiNicolantonio","year":"2012","journal-title":"Futur Cardiol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0325","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jacc.2012.12.043","article-title":"Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?","volume":"61","author":"Bikdeli","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.12.009_bb0330","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00019053-200017050-00002","article-title":"Healthcare costs of patients with heart failure treated with torasemide or furosemide","volume":"17","author":"Stroupe","year":"2000","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.ahj.2014.12.009_bb0335","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0149-2918(99)80007-1","article-title":"A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure","volume":"21","author":"Noe","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.ahj.2014.12.009_bb0340","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2165\/00019053-200119060-00006","article-title":"Torasemide: a pharmacoeconomic review of its use in chronic heart failure","volume":"19","author":"Young","year":"2001","journal-title":"Pharmacoeconomics"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870314007467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870314007467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:54:17Z","timestamp":1757570057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870314007467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0002870314007467"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2014.12.009","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A reappraisal of loop diuretic choice in heart failure patients","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2014.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}